3.1 Concentrations, Dilutions, Alligations & Reconstitution

Key Takeaways

  • Percentage strength expressions must be matched strictly to physical states: % w/v represents grams of solute per 100 mL of solution, % v/v represents millilitres of liquid solute per 100 mL of solution, and % w/w represents grams of solute per 100 g of final preparation.

  • Ratio strength 1:X represents 1 part of active drug per X parts of preparation (e.g., epinephrine 1:1,000 provides 1 mg/mL or 0.1% w/v for intramuscular anaphylaxis, whereas 1:10,000 provides 0.1 mg/mL or 0.01% w/v for intravenous cardiac resuscitation).

  • Parts per million (ppm) expresses trace solute levels as parts per 1,000,000 parts (equivalent to 1 mg/L1\text{ mg/L} or 1 μg/mL1\ \mu\text{g/mL} in aqueous media, where 1 ppm=0.0001% w/v1\text{ ppm} = 0.0001\%\text{ w/v}).

  • Alligation alternate determines the proportional parts of two different ingredient strengths needed to compound an intermediate target strength, while alligation medial calculates the resulting weighted average concentration when mixing known quantities of multiple components.

  • Dry powder antibiotic reconstitution must account for powder displacement volume via Vfinal=Vdiluent+VpowderV_{\text{final}} = V_{\text{diluent}} + V_{\text{powder}}, ensuring correct diluent measurement when altering commercial suspension concentrations for pediatric patients.

Last updated: October 2026

3.1 Concentrations, Dilutions, Alligations & Reconstitution

Pharmaceutical calculations form the foundation of safe pharmacy practice and product compounding in Canada. Accuracy in posology, concentration expression, and volumetric compounding protects patients from subtherapeutic treatment failures and toxic overdoses. In community, hospital, and compounding practice environments, pharmacists must fluidly translate between percentage strengths, ratio concentrations, parts per million, and volumetric dilutions.


Expression of Drug Concentrations in Canadian Pharmacy

Drug concentration defines the quantity of an active pharmaceutical ingredient (API) relative to the total quantity of the pharmaceutical preparation. In Canadian pharmacy practice, concentrations are conventionally categorized into three distinct percentage types based on the physical state of the solute and the solvent:

ExpressionDefinitionStandard Dimensional UnitsCommon Clinical & Compounding Applications
Percent Weight-in-Volume (% w/v)Grams of solute in 100 mL100\text{ mL} of solutiong/100 mL\text{g}/100\text{ mL}Oral liquids, IV infusions, topical lotions, ophthalmic solutions
Percent Volume-in-Volume (% v/v)Millilitres of liquid solute in 100 mL100\text{ mL} of solutionmL/100 mL\text{mL}/100\text{ mL}Hydroalcoholic solutions, rubbing alcohol (e.g., 70% v/v70\%\text{ v/v} isopropyl alcohol)
Percent Weight-in-Weight (% w/w)Grams of solute in 100 g100\text{ g} of final preparationg/100 g\text{g}/100\text{ g}Semisolid ointments, creams, pastes, bulk powders

Note

Unless specified otherwise in official compendia or prescription orders, a percentage concentration for a solid dissolved in a liquid is assumed to represent % w/v, a liquid dissolved in a liquid represents % v/v, and a solid compounded into a semisolid base represents % w/w.

Ratio Strength

Ratio strength expresses concentration as parts of active drug relative to parts of the total formulation. By international convention:

  • For solids in liquids: 1:X=1 g of solute in X mL of solution1:X = 1\text{ g of solute in } X\text{ mL of solution}.
  • For liquids in liquids: 1:X=1 mL of solute in X mL of solution1:X = 1\text{ mL of solute in } X\text{ mL of solution}.
  • For solids in solids: 1:X=1 g of solute in X g of preparation1:X = 1\text{ g of solute in } X\text{ g of preparation}.

A critical patient-safety application in Canadian acute care is the posology of epinephrine (adrenaline), where decimal or ratio misinterpretations can cause fatal cardiac arrhythmias or cerebral hemorrhage:

  • Epinephrine 1:1,000 w/v1:1,000\text{ w/v}: 1 g1,000 mL=1,000 mg1,000 mL=1 mg/mL=0.1% w/v\frac{1\text{ g}}{1,000\text{ mL}} = \frac{1,000\text{ mg}}{1,000\text{ mL}} = 1\text{ mg/mL} = 0.1\%\text{ w/v} Clinical Indication: Intramuscular injection into the anterolateral thigh for acute anaphylaxis.
  • Epinephrine 1:10,000 w/v1:10,000\text{ w/v}: 1 g10,000 mL=1,000 mg10,000 mL=0.1 mg/mL=0.01% w/v\frac{1\text{ g}}{10,000\text{ mL}} = \frac{1,000\text{ mg}}{10,000\text{ mL}} = 0.1\text{ mg/mL} = 0.01\%\text{ w/v} Clinical Indication: Intravenous administration during Advanced Cardiac Life Support (ACLS) resuscitation protocols.

Parts Per Million (PPM) & Parts Per Billion (PPB)

For extremely dilute solutions, such as municipal water fluoridation, residual solvent limits, and trace heavy metal impurities, concentration is expressed as parts per million (ppm):

ppm=Parts of Solute1,000,000 Parts of Total Preparation\text{ppm} = \frac{\text{Parts of Solute}}{1,000,000\text{ Parts of Total Preparation}}

In dilute aqueous systems where the specific gravity approximates 1.0 g/mL1.0\text{ g/mL} (1 L≈1,000,000 mg1\text{ L} \approx 1,000,000\text{ mg}):

  • 1 ppm=1 mg of solute per 1 L of water=1 μg/mL1\text{ ppm} = 1\text{ mg of solute per } 1\text{ L of water} = 1\ \mu\text{g/mL}.
  • In percentage terms: 1 ppm=11,000,000×100%=0.0001% w/v1\text{ ppm} = \frac{1}{1,000,000} \times 100\% = 0.0001\%\text{ w/v}.

For example, if Health Canada specifies that drinking water contains 0.7 ppm0.7\text{ ppm} of fluoride ion, each litre of water contains 0.7 mg0.7\text{ mg} of fluoride, which equals 0.00007% w/v0.00007\%\text{ w/v}.


Dilution and Concentration Principles: The C1V1=C2V2C_1 V_1 = C_2 V_2 Relationship

When diluting a concentrated stock solution with an inactive vehicle (such as sterile water for injection or petrolatum) or concentrating a preparation by vehicle evaporation, the absolute mass of the active pharmaceutical ingredient remains constant. This conservation of mass yields the universal inverse proportionality equation:

C1V1=C2V2orQ1C1=Q2C2C_1 V_1 = C_2 V_2 \quad \text{or} \quad Q_1 C_1 = Q_2 C_2

Where C1C_1 and C2C_2 represent initial and final concentrations, and V1V_1 and V2V_2 (or Q1Q_1 and Q2Q_2) represent initial and final volumes or weights.

Important

Both concentration terms (C1C_1 and C2C_2) must share identical dimensional units (e.g., both in %, both in mg/mL\text{mg/mL}, or both in ratio format), and both quantity terms (V1V_1 and V2V_2) must share identical volumetric or gravimetric units (e.g., both in mL\text{mL} or both in g\text{g}).

Step-by-Step Worked Dilution Example

Clinical Scenario: A hospital pharmacist receives a physician order to compound 500 mL500\text{ mL} of a 0.05% w/v0.05\%\text{ w/v} chlorhexidine gluconate topical wound rinse. The pharmacy stock inventory contains only concentrated 4.0% w/v4.0\%\text{ w/v} chlorhexidine gluconate surgical scrub.

  1. Identify the Knowns and Unknowns:

    • Stock concentration (C1C_1) = 4.0% w/v4.0\%\text{ w/v}
    • Stock volume needed (V1V_1) = ? mL?\text{ mL}
    • Desired target concentration (C2C_2) = 0.05% w/v0.05\%\text{ w/v}
    • Desired target volume (V2V_2) = 500 mL500\text{ mL}
  2. Set up the Equation: (4.0%)×V1=(0.05%)×500 mL(4.0\%) \times V_1 = (0.05\%) \times 500\text{ mL}

  3. Solve for V1V_1: V1=0.05×500 mL4.0=254.0=6.25 mLV_1 = \frac{0.05 \times 500\text{ mL}}{4.0} = \frac{25}{4.0} = 6.25\text{ mL}

  4. Determine the Required Diluent Volume: Vdiluent=Vfinal−V1=500 mL−6.25 mL=493.75 mLV_{\text{diluent}} = V_{\text{final}} - V_1 = 500\text{ mL} - 6.25\text{ mL} = 493.75\text{ mL}

  5. Compounding Procedure: Accurately measure 6.25 mL6.25\text{ mL} of the 4.0%4.0\% stock solution using a calibrated syringe, transfer to a volumetric cylinder, and bring to a total volume of 500 mL500\text{ mL} with sterile water for irrigation.


Alligation Methods: Alternate and Medial Compounding Math

When combining two or more preparations of differing strengths to obtain an intermediate strength, simple linear dilution formulas cannot be applied directly if both components contain active ingredient. Pharmacists employ alligation alternate to calculate the relative proportions of ingredients, and alligation medial to determine the resulting strength of a mixture.

Alligation Alternate (Grid Method)

Alligation alternate establishes the relative parts of a higher-strength component and a lower-strength component needed to achieve an intermediate target strength:

  1. Place the desired target strength in the center of the grid.
  2. Place the higher available strength at the top-left and the lower available strength (or pure vehicle at 0%0\%) at the bottom-left.
  3. Subtract diagonally across the grid (always taking the absolute difference):
    • Parts of Higher Strength =∣Desired Strength−Lower Strength∣= |\text{Desired Strength} - \text{Lower Strength}|
    • Parts of Lower Strength =∣Higher Strength−Desired Strength∣= |\text{Higher Strength} - \text{Desired Strength}|
  4. Sum the parts to obtain the total parts of the final formulation.
  5. Convert the proportional parts to actual weights or volumes.
 Higher Strength (H)                  Parts of Higher = |Desired - Lower|
                        Desired (D)
 Lower Strength (L)                   Parts of Lower  = |Higher - Desired|
 ------------------------------------------------------------------------
                                      Total Parts     = Sum of Parts

Step-by-Step Worked Alligation Alternate Example

Clinical Scenario: A dermatologist prescribes 120 g120\text{ g} of a 1.5% w/w1.5\%\text{ w/w} hydrocortisone cream. The pharmacy has in stock 2.5% w/w2.5\%\text{ w/w} hydrocortisone cream and 0.5% w/w0.5\%\text{ w/w} hydrocortisone cream. How many grams of each cream must be blended?

  1. Set Up the Alligation Grid:

    • Higher strength: 2.5%2.5\%
    • Lower strength: 0.5%0.5\%
    • Desired strength: 1.5%1.5\%
  2. Diagonal Subtraction:

    • Parts of 2.5%2.5\% cream =∣1.5−0.5∣=1.0 part= |1.5 - 0.5| = 1.0\text{ part}
    • Parts of 0.5%0.5\% cream =∣2.5−1.5∣=1.0 part= |2.5 - 1.5| = 1.0\text{ part}
    • Total parts =1.0+1.0=2.0 parts= 1.0 + 1.0 = 2.0\text{ parts}
  3. Calculate Component Proportions and Weights: Weight of 2.5% cream=1.0 part2.0 parts×120 g=60 g\text{Weight of } 2.5\%\text{ cream} = \frac{1.0\text{ part}}{2.0\text{ parts}} \times 120\text{ g} = 60\text{ g} Weight of 0.5% cream=1.0 part2.0 parts×120 g=60 g\text{Weight of } 0.5\%\text{ cream} = \frac{1.0\text{ part}}{2.0\text{ parts}} \times 120\text{ g} = 60\text{ g}

  4. Proof / Verification:

    • Drug from 2.5%2.5\% cream: 60 g×0.025=1.5 g60\text{ g} \times 0.025 = 1.5\text{ g}
    • Drug from 0.5%0.5\% cream: 60 g×0.005=0.3 g60\text{ g} \times 0.005 = 0.3\text{ g}
    • Total active drug: 1.5 g+0.3 g=1.8 g1.5\text{ g} + 0.3\text{ g} = 1.8\text{ g}
    • Final concentration: 1.8 g120 g×100%=1.5% w/w\frac{1.8\text{ g}}{120\text{ g}} \times 100\% = 1.5\%\text{ w/w}. The calculation is confirmed.

Alligation Medial (Weighted Average)

Alligation medial calculates the final concentration obtained when blending known quantities of preparations with known strengths. It represents a weighted arithmetic mean:

Final Concentration (%)=∑(Quantityi×Concentrationi)∑Quantityi\text{Final Concentration (\%)} = \frac{\sum (\text{Quantity}_i \times \text{Concentration}_i)}{\sum \text{Quantity}_i}

FeatureAlligation AlternateAlligation Medial
Primary ObjectiveFind unknown quantities/proportions to hit a target strengthFind the resulting strength when mixing known quantities
Known InputsInitial strengths and desired final strengthSpecific quantities and strengths of each ingredient
Unknown OutputMass or volume of each ingredient requiredFinal percentage concentration of the blended mixture
Exam Clue"How many grams of each are needed to compound...""What is the resulting strength when mixing..."

Dry Powder Reconstitution and Volume Displacement

Many pharmaceutical anti-infective suspensions (e.g., amoxicillin, amoxicillin/clavulanate, cephalexin, azithromycin) are manufactured as dry powder mixtures because of aqueous instability. When reconstituted with purified water, the dry powder dissolves and occupies physical space, contributing to the total final volume. This is termed the powder volume or displacement volume (VpowderV_{\text{powder}}):

Vfinal=Vdiluent+VpowderV_{\text{final}} = V_{\text{diluent}} + V_{\text{powder}} Vpowder=Vfinal−VdiluentV_{\text{powder}} = V_{\text{final}} - V_{\text{diluent}}

Failure to account for powder volume displacement when modifying commercial suspension concentrations leads to severe dosing errors.

Step-by-Step Worked Reconstitution Problem

Clinical Scenario: A community pharmacist receives a prescription for amoxicillin oral suspension for an infant requiring fluid restriction. The physician orders a customized concentration of 500 mg/5 mL500\text{ mg}/5\text{ mL} (100 mg/mL100\text{ mg/mL}) using a standard commercial bottle labeled: Amoxicillin Powder for Oral Suspension 250 mg/5 mL250\text{ mg}/5\text{ mL}, 100 mL100\text{ mL} when reconstituted. To reconstitute, add 68 mL68\text{ mL} of water in two portions and shake vigorously.

  1. Determine the Total Active Drug in the Bottle: Total Drug=100 mL×250 mg5 mL=5,000 mg\text{Total Drug} = 100\text{ mL} \times \frac{250\text{ mg}}{5\text{ mL}} = 5,000\text{ mg}

  2. Calculate the Dry Powder Volume (VpowderV_{\text{powder}}): Vpowder=Vstandard final−Vlabeled diluent=100 mL−68 mL=32 mLV_{\text{powder}} = V_{\text{standard final}} - V_{\text{labeled diluent}} = 100\text{ mL} - 68\text{ mL} = 32\text{ mL}

  3. Calculate the Desired Final Volume for the Custom Concentration: Target Final Volume=Total Drug (mg)Target Concentration (mg/mL)=5,000 mg100 mg/mL=50 mL\text{Target Final Volume} = \frac{\text{Total Drug (mg)}}{\text{Target Concentration (mg/mL)}} = \frac{5,000\text{ mg}}{100\text{ mg/mL}} = 50\text{ mL}

  4. Calculate the Diluent Volume to Add: Vwater to add=Vtarget final−Vpowder=50 mL−32 mL=18 mLV_{\text{water to add}} = V_{\text{target final}} - V_{\text{powder}} = 50\text{ mL} - 32\text{ mL} = 18\text{ mL}

Important

Adding 50 mL50\text{ mL} of water directly would yield a final volume of 82 mL82\text{ mL} (50 mL+32 mL50\text{ mL} + 32\text{ mL}), producing a dangerously subtherapeutic concentration of 61 mg/mL61\text{ mg/mL} (305 mg/5 mL305\text{ mg}/5\text{ mL}) instead of the intended 100 mg/mL100\text{ mg/mL}.


Compounding Pitfalls & Verification Best Practices

To ensure compounding accuracy and score maximally on calculations sections of entry-to-practice exams, candidates must recognize standard traps:

  • Unit Discordance: Never mix milligrams and grams, or millilitres and litres, without explicit conversion factors.
  • Specific Gravity Omission in % w/w to % w/v Conversions: For non-aqueous liquids or dense syrups (e.g., glycerin with specific gravity 1.26 g/mL1.26\text{ g/mL}), 100 g100\text{ g} does not equal 100 mL100\text{ mL}. Use Volume=WeightSpecific Gravity\text{Volume} = \frac{\text{Weight}}{\text{Specific Gravity}}.
  • Non-Additive Volumes: Mixing concentrated alcohol with water causes volume contraction due to intermolecular hydrogen bonding. In compounding 70% v/v70\%\text{ v/v} ethanol, pharmacists add water quantum sufficiat (q.s.) to the calibration mark in a volumetric flask rather than measuring separate additive volumes.
Test Your Knowledge

A stock solution of benzalkonium chloride is labeled 1:750 w/v1:750\text{ w/v}. What is the equivalent percentage strength (% w/v) and the volume of this stock solution required to prepare 600 mL600\text{ mL} of a 1:5,000 w/v1:5,000\text{ w/v} solution?

A

0.133% w/v0.133\%\text{ w/v} and 180 mL180\text{ mL}

B

0.075% w/v0.075\%\text{ w/v} and 45 mL45\text{ mL}

C

1.33% w/v1.33\%\text{ w/v} and 9 mL9\text{ mL}

D

0.133% w/v0.133\%\text{ w/v} and 90 mL90\text{ mL}

Test Your Knowledge

A prescriber orders 240 g240\text{ g} of a 1.25% w/w1.25\%\text{ w/w} hydrocortisone ointment. The pharmacy inventory includes a 2.5% w/w2.5\%\text{ w/w} hydrocortisone ointment and a 0.5% w/w0.5\%\text{ w/w} hydrocortisone ointment. How many grams of the 2.5%2.5\% ointment and the 0.5%0.5\% ointment, respectively, must be blended to prepare this prescription?

A

90 g90\text{ g} of 2.5%2.5\% ointment and 150 g150\text{ g} of 0.5%0.5\% ointment

B

120 g120\text{ g} of 2.5%2.5\% ointment and 120 g120\text{ g} of 0.5%0.5\% ointment

C

150 g150\text{ g} of 2.5%2.5\% ointment and 90 g90\text{ g} of 0.5%0.5\% ointment

D

60 g60\text{ g} of 2.5%2.5\% ointment and 180 g180\text{ g} of 0.5%0.5\% ointment

Test Your Knowledge

A pharmacist must reconstitute a commercial bottle of cephalexin powder for oral suspension. The manufacturer label indicates that adding 71 mL71\text{ mL} of purified water yields 100 mL100\text{ mL} of a 250 mg/5 mL250\text{ mg}/5\text{ mL} suspension (5,000 mg5,000\text{ mg} total cephalexin). The prescriber directs the pharmacy to prepare a customized concentration of 125 mg/5 mL125\text{ mg}/5\text{ mL} using this single bottle. What volume of purified water must be added to the dry powder to achieve this exact concentration?

A

200 mL200\text{ mL}

B

129 mL129\text{ mL}

C

171 mL171\text{ mL}

D

142 mL142\text{ mL}

Sections you finish are checked off in the contents.